Puerarin exhibits greater distribution and longer retention time in neurons than astrocytes in a co-cultured system

The phytoestrogen puerarin has been shown to protect neurons and astrocytes in the brain, and is therefore an attractive drug in the treatment of Alzheimer′s disease, Parkinson′s disease and cerebral ischemia. Whether puerarin exhibits the same biological processes in neurons and astrocytes in vitro has rarely been reported. In this study, cortical neurons and astrocytes of newborn Sprague-Dawley rats were separated, identified and co-cultured in a system based on Transwell membranes. The retention time and distribution of puerarin in each cell type was detected by fluorescence spectrophotometry and fluorescence microscope. The concentration of puerarin in both co-cultured and separately cultured neurons was greater than that of astrocytes. Puerarin concentration reached a maximum 20 minutes after it was added. At 60 minutes after its addition, a scant amount of drug was detected in astrocytes; however in both separately cultured and co-cultured neurons, the concentration of puerarin achieved a stable level of about 12.8 ng/mL. The results indicate that puerarin had a higher concentration and longer retention time in neurons than that observed in astrocytes.

[1]  Xiao-yu Xu,et al.  Progress on the pharmacological research of puerarin: a review. , 2014, Chinese journal of natural medicines.

[2]  Xiaoyu Xu,et al.  A Novel Brain Neurovascular Unit Model with Neurons, Astrocytes and Microvascular Endothelial Cells of Rat , 2013, International journal of biological sciences.

[3]  Ning Li,et al.  Determination of glibenclamide and puerarin in rat plasma by UPLC-MS/MS: application to their pharmacokinetic interaction study. , 2013, Talanta.

[4]  Y. Liu,et al.  Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway , 2013, Free radical research.

[5]  Jifen Zhang,et al.  HPLC-APCI-MS/MS method for the determination of catalpol in rat plasma and cerebrospinal fluid: application to an in vivo pharmacokinetic study. , 2012, Journal of pharmaceutical and biomedical analysis.

[6]  Qin Zhang,et al.  Puerarin protects differentiated PC12 cells from H2O2‐induced apoptosis through the PI3K/Akt signalling pathway , 2012, Cell biology international.

[7]  Chao Yu,et al.  Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation. , 2012, International journal of oncology.

[8]  Martin M. F. Choi,et al.  Determination of puerarin in pharmaceutical and biological samples by capillary zone electrophoresis with UV detection. , 2012, Talanta.

[9]  Guoqi Zhu,et al.  Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death , 2012, Neurochemistry International.

[10]  Ling-bo Qu,et al.  Determination of puerarin in biological samples and its application to a pharmacokinetic study by flow-injection chemiluminescence. , 2011, Luminescence : the journal of biological and chemical luminescence.

[11]  D. Cai,et al.  Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway , 2011, Brain Research Bulletin.

[12]  Nagendra Singh Chauhan,et al.  Spectrofluorimetric estimation of puerarin in Pueraria tuberosa. , 2011, Acta poloniae pharmaceutica.

[13]  G. Wang,et al.  Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. , 2010, European journal of pharmacology.

[14]  Shui-Tein Chen,et al.  Neurocytoprotective effects of the bioactive constituents of Pueraria thomsonii in 6-hydroxydopamine (6-OHDA)-treated nerve growth factor (NGF)-differentiated PC12 cells. , 2010, Phytochemistry.

[15]  Shu Yang,et al.  Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. , 2010, Planta medica.

[16]  Hu-qing Wang,et al.  Protective effects and mechanism of puerarin on learning-memory disorder after global cerebral ischemia-reperfusion injury in rats , 2009, Chinese journal of integrative medicine.

[17]  J. Sheu,et al.  Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats , 2009, Journal of Biomedical Science.

[18]  M. Liu,et al.  Puerarin for acute ischaemic stroke. , 2008, The Cochrane database of systematic reviews.

[19]  Xiaohong Xu,et al.  Inhibition of excitatory amino acid efflux contributes to protective effects of puerarin against cerebral ischemia in rats. , 2007, Biomedical and environmental sciences : BES.

[20]  J. Wei,et al.  Puerarin injection for unstable angina pectoris. , 2016, The Cochrane database of systematic reviews.

[21]  Xiaohong Xu,et al.  Effects of Puerarin on Learning-Memory and Amino Acid Transmitters of Brain in Ovariectomized Mice , 2004, Planta medica.

[22]  Xueli Li,et al.  Experimental study on the protective effect of puerarin to Parkinson disease. , 2003, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[23]  Xiaohong Xu,et al.  Effects of puerarin on D-galactose-induced memory deficits in mice. , 2002, Acta pharmacologica Sinica.

[24]  H. Kobayashi,et al.  Simultaneous high-performance liquid chromatographic determination of puerarin, daidzin, paeoniflorin, liquiritin, cinnamic acid, cinnamaldehyde and glycyrrhizin in Kampo medicines. , 1999, Journal of pharmaceutical and biomedical analysis.